Skip to content
  • Friday, 14 August 2026
  • 9:24 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
Laboratory Automation & Robotics

Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID

Lana Keisha Jul 22, 2026 0

A significant paradigm shift is underway in small-molecule drug discovery, as a pioneering collaboration between Ginkgo Datapoints, Tangible Scientific, and…

Read More
Laboratory Automation & Robotics

Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID

Lana Keisha Jul 14, 2026 0

A significant shift is underway in the landscape of small-molecule drug discovery, as a new collaborative platform seeks to revolutionize…

Read More
Laboratory Automation & Robotics

Ginkgo, Tangible and Inductive Bio Launch ADME-One Platform to Revolutionize Early Drug Discovery Decisions with AI and Automation

Lana Keisha Jul 6, 2026 0

A significant shift is underway in small-molecule drug discovery, as a new collaboration between Ginkgo Datapoints, Tangible Scientific, and Inductive…

Read More
Laboratory Automation & Robotics

Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID

Lana Keisha Jun 29, 2026 0

For decades, the pharmaceutical industry has grappled with the inherent inefficiencies of drug discovery, a process often likened to searching…

Read More
Laboratory Automation & Robotics

Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID

Lana Keisha Jun 22, 2026 0

A significant paradigm shift is underway in the pharmaceutical industry’s approach to small-molecule drug discovery, as a new collaborative platform,…

Read More
Laboratory Automation & Robotics

Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID

Lana Keisha Jun 14, 2026 0

A new collaborative platform, ADME-One, has been launched by Ginkgo Datapoints, Tangible Scientific, and Inductive Bio, signaling a significant shift…

Read More
Pharmaceutical R&D

Ginkgo Bioworks CEO Jason Kelly Discusses Autonomous Labs and the Future of Biopharma R&D

Teuku Ryan May 10, 2026 0

The landscape of biopharmaceutical research and development (R&D) is undergoing a seismic shift, driven by the integration of advanced robotics…

Read More
Pharmaceutical R&D

The Autonomous Revolution: How Ginkgo Bioworks is Driving a Paradigm Shift in Biopharma R&D

Teuku Ryan May 9, 2026 0

The biopharmaceutical industry, long reliant on the meticulous, hands-on work of human researchers, is on the cusp of a profound…

Read More
Pharmaceutical R&D

Ginkgo Bioworks CEO Jason Kelly Discusses Autonomous Labs and the Future of Biopharma R&D

Teuku Ryan May 8, 2026 0

The biopharmaceutical industry is on the cusp of a profound transformation, driven by the burgeoning integration of artificial intelligence (AI)…

Read More
The World Health Organization Targets Urgent Antibiotic Development to Combat Evolving Drug ResistanceUnlocking Life’s Genesis: The Nanozymes Hypothesis Offers a New Framework for Earth’s Origin StoryThe Naked Mole Rat’s Secret to Longevity: A Gene Transfer Breakthrough Offers Hope for Human HealthspanUnprecedented Growth Rates and Early Genetic Origins of Chronic Myeloid Leukemia Revealed in Landmark Genomic Study
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ